Medical Equipment

Breast Cancer Diagnostics Market Forecast Highlighting Industry Progress And Growth Trends

April 10, 2026April 10, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Breast Cancer Diagnostics Market From 2026 To 2030?

The breast cancer diagnostics market has demonstrated robust growth in recent years. It is projected to expand from $5 billion in 2025 to $5.42 billion in 2026, at a compound annual growth rate (CAGR) of 8.3%. The growth observed in the historic period stems from several factors, including the rising incidence of breast cancer globally, increased awareness of early cancer screening, the expansion of diagnostic imaging infrastructure, the growing availability of biomarker-based tests, and enhancements in biopsy accuracy and safety.

The breast cancer diagnostics market is anticipated to experience substantial growth over the coming years. This market is projected to reach $7.28 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this anticipated growth include the wider adoption of precision oncology diagnostics, increased investments in AI-powered diagnostic platforms, a rising need for less invasive testing methods, the expansion of widespread screening initiatives, and ongoing innovations in molecular diagnostic technologies. Key trends expected during this period encompass the growing integration of AI-assisted imaging analysis, an uptick in genomic and molecular testing, the increased application of liquid biopsy techniques, the development of sophisticated non-ionizing imaging approaches, and a stronger emphasis on prompt and tailored diagnoses.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp

What Significant Factors Are Influencing The Breast Cancer Diagnostics Market Expansion?

Government initiatives and funding directed at breast cancer are anticipated to stimulate the expansion of the breast cancer diagnostics market moving forward. These government initiatives and funding represent a form of financial aid provided by the government to selected entities with concepts or projects that contribute to and enhance public services and the economy. Such governmental support is vital for bolstering breast cancer research, prevention, and treatment, with various programs being rolled out to increase public awareness, encourage early detection through screening and mammography, and provide financial assistance to underserved communities for breast cancer testing and treatment. For example, The Australian Government Department of Health (DoH), the Australia-based Government agency, allocated $40.7 million in its 2022-23 budget to improve access to testing and screening services for different types of cancers, addressing disruptions caused by the COVID-19 pandemic, and facilitating timely referrals, swift diagnosis, and early intervention. This allocation included $9.7 million specifically designated for breast cancer screening. Therefore, government initiatives and funding for breast cancer are instrumental in driving the growth of the breast cancer diagnostics market.

How Are Different Segments Classified In The Breast Cancer Diagnostics Market Segment Analysis?

The breast cancer diagnostics market covered in this report is segmented –

1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types

2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies

3) By Cancer Type: BRCA Breast Cancer, ER And PR Breast Cancer, HER 2 Breast Cancer, Triple-Negative Breast Cancer, Other Cancer Types

4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies

5) By End Users: Hospitals And Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers

Subsegments:

1) By Imaging: Mammography, Ultrasound Imaging, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Tomosynthesis

2) By Biopsy: Needle Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy (FNA), Stereotactic Biopsy

3) By Genomic Tests: Oncotype DX, MammaPrint, PAM50, BRCA1 Or 2 Testing

4) By Blood Tests: Liquid Biopsy, Circulating Tumor DNA (ctDNA) Tests, Circulating Tumor Cells (CTCs) Tests

5) By Other Types: Hormone Receptor Tests, HER2 Tests, Genetic Mutation Testing

What Trends Are Affecting The Direction Of The Breast Cancer Diagnostics Market?

Leading companies in the breast cancer diagnostics market are concentrating on developing innovative AI-powered diagnostic solutions, such as advanced pathology scoring platforms, to boost accuracy, streamline workflows, and enable personalized treatment planning. AI-based diagnostic platforms are defined as technologies that leverage machine learning and deep-learning algorithms to analyze medical imaging, pathology slides, or clinical data, providing diagnostic insights or risk stratifications that support clinical decision-making. For instance, in September 2024, Ibex Medical Analytics, an Israel-based digital pathology company, unveiled its expanded AI platform for breast cancer diagnostics, introducing a fully automated zero-click HER2 immunohistochemistry (IHC) scoring feature within its Ibex Breast HER2 module. This tool accurately identifies invasive cancer areas, classifies HER2 expression levels (0, 1+, 2+, 3+), and assists breast cancer diagnosis and treatment-pathway decisions with enhanced accuracy and workflow efficiency.

Who Are The Companies Driving Activity In The Breast Cancer Diagnostics Market?

Major companies operating in the breast cancer diagnostics market are Abbott Laboratories, Myriad Genetics Inc., Hologic Inc., Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fisher Scientific Inc., Siemens AG, NanoString Technologies Inc., Gamma Medica Inc., Aurora Imaging Technology Inc., Dilon Technologies Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Micrima Limited, Provista Diagnostics Inc., Leica Biosystems Nussloch GmbH, bioTheranostics Inc., Bio-Rad Laboratories Inc., Illumina Inc., Biocept Inc., Quest Diagnostics Incorporated, Agilent Technologies Inc., Cepheid, Guardant Health Inc., Invitae Corporation, Natera Inc., NeoGenomics Laboratories Inc., Oncocyte Corporation, PerkinElmer Inc., Sysmex Corporation, Veracyte Inc.

Get The Full Breast Cancer Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report

Which Region Dominates The Breast Cancer Diagnostics Market By Market Share?

North America was the largest region in the breast cancer diagnostics market in 2025. Asia-Pacific was the second largest region in the breast cancer diagnostics industry. The regions covered in the breast cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Breast Cancer Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=3284&type=smp

Browse Through More Reports Similar to the Global Breast Cancer Diagnostics Market 2026, By The Business Research Company

Next Generation Gynecological Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/next-generation-gynecological-cancer-diagnostics-global-market-report

Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Breast Imaging Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/breast-imaging-technologies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795